MENU
+Compare
MEHCQ
Stock ticker: OTC
AS OF
Oct 17 closing price
Price
$3.20
Change
+$0.04 (+1.27%)
Capitalization
88.13M

MEHCQ 23andMe Holding Co. Forecast, Technical & Fundamental Analysis

23andMe Holding Co is a consumer-facing healthcare technology company, involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail... Show more

MEHCQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MEHCQ with price predictions
Oct 17, 2025

MEHCQ sees MACD Histogram crosses below signal line

MEHCQ saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 06, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MEHCQ as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MEHCQ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MEHCQ entered a downward trend on October 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MEHCQ advanced for three days, in of 230 cases, the price rose further within the following month. The odds of a continued upward trend are .

MEHCQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.203) is normal, around the industry mean (12.122). P/E Ratio (0.000) is within average values for comparable stocks, (140.368). MEHCQ's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.782). MEHCQ has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.485) is also within normal values, averaging (9.606).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MEHCQ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MEHCQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
MEHCQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSLYF22.81N/A
N/A
Nestle Malaysia BHD
ASAZF35.24N/A
N/A
Assa Abloy AB
CSNVF19.42N/A
N/A
Corbion NV
ELRNF1.65N/A
N/A
Elron Ventures Ltd.
GARWF0.05-0.01
-14.25%
Golden Arrow Resource Corp.

MEHCQ and Stocks

Correlation & Price change

A.I.dvisor tells us that MEHCQ and QDEL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEHCQ and QDEL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEHCQ
1D Price
Change %
MEHCQ100%
+1.27%
QDEL - MEHCQ
31%
Poorly correlated
-1.02%
OM - MEHCQ
30%
Poorly correlated
-0.60%
BFLY - MEHCQ
28%
Poorly correlated
-5.36%
MDXH - MEHCQ
27%
Poorly correlated
-0.74%
EW - MEHCQ
26%
Poorly correlated
+2.74%
More